ClinicalTrials.Veeva

Menu

Magnetic Resonance Fingerprinting in the Imaging of Endometrial Cancer (MARF-E)

I

Institute of Hospitalization and Scientific Care (IRCCS)

Status

Enrolling

Conditions

Endometrial Cancer

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

In this context, the aim of this study is to investigate the role of MRF in endometrial cancer. Several applications are possible. Firstly, T1-, T2- and DWI-mappings can be associated to molecular risk group classification, in order to stratify patients' risk without recurring to surgery. MRF parameters can be also correlated to prognosis, both in terms of disease-free survival (DFS) and overall survival (OS).

Enrollment

150 estimated patients

Sex

Female

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients with biopsy-proven endometrial cancer;
  • Women aged > 18 years old;
  • Signed Informed consent.

Exclusion criteria

  • Previous history of neoplasm;
  • Concurrent malignancies at other sites.

Trial contacts and locations

1

Loading...

Central trial contact

Benedetta B Gui, MD; Benedetta B Gui, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems